Proton Therapy Market Growth Factors, Competitive Landscape and Revenue Forecast till 2023

The worldwide proton therapy market is projected to exhibit a healthy CAGR during the forecast period. Proton therapy is the most advanced and precise form of radiation therapy and mostly used in the treatment of cancer. Rise in occurrence of cancer patients, and improvement in insurance coverage for proton therapy are likely drive the growth. The other driving factors include rising awareness among people, surge in demand for proton therapy and increase in consumption of tobacco.

In 2015, according to the World Health Organization, over 1.1 billion people smoked tobacco and the number is still increasing. Technical progressions and increase in health care spending are the other factors driving the growth of proton therapy. However, high treatment cost is likely to hamper the growth in the years to come.

In July 2015, the state government of Victoria invested approximately AUD 2 million (USD 1.53 million) to develop a National Centre for Proton Beam Therapy at the Victorian Comprehensive Cancer Centre (VCCC). The new center is expected to offer treatment to the patients in Australia.

Top Players:• IBA
• Mitsubishi
• Optivus
• Hitachi
• Mevion
• Varian
• ProNova
• Sumitomo

Request free sample to get a complete list of companies @ https://www.millioninsights.com/industry-reports/proton-therapy-market/request-sample

Key players in the proton therapy are partnering and collaborating with the other corporations to enhance their skills. In May 2017, Mevion entered into strategic teamwork with Med Photon GmbH to integrate med Photon’s Imaging Ring with the HYPERSCAN with MEVION S250i system, for delivering efficient and precise treatment.

Market Segment:

Key Products:• Equipment
• Drugs

Key Applications:• Tumor Therapy
• Others

Key Regions
• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Columbia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

North America is one of the prominent regions and will continue to account for a large share in the proton therapy market in the forecast period, owing to the high acceptance of this therapy and strong reimbursement framework.

Also, in September 2016, Royal Philips and IBA together launched Ambient Experience solution for the proton therapy support of IBA’s Proteus PLUS. The novel patient-centric solution was planned to surge operational effectiveness and patient comfort. Mergers, expansions, acquisitions, and new product development are some of the most extensively accepted strategies by industry companies, both small and large.

Browse Related Category Reports @ https://industriesstudyreport.wordpress.com/

Report contents include• Analysis of the market including revenues, future growth, market outlook
• Historical data and forecast
• Regional analysis including growth estimates
• Analyzes the end user markets including growth estimates.
• Company Profiles including products, sales/revenues, and market position
• Market structure, market drivers, and restraints.